Blog
RSS FeedPosted by Michael Wonder on 08 Jan 2018
Significant step forward for treating people with head and neck cancer
21 December 2018 - Funding cetuximab for patients with head and neck cancer will be a significant advance for treating ...
Posted by Michael Wonder on 02 Jan 2018
New Zealand Pharmaceutical Schedule - 1 January 2018
1 January 2018 - The January 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 20 Dec 2017
Decision to fund cetuximab for head and neck cancer
20 December 2017 - PHARMAC is pleased to announce our decision to fund cetuximab (Erbitux) from 1 February 2018 for ...
Posted by Michael Wonder on 14 Dec 2017
Up to 3,000 women to benefit from PHARMAC decision
14 December 2017 - Post-menopausal women with early breast cancer will soon be able to have funded zoledronic acid, to ...
Posted by Michael Wonder on 12 Dec 2017
Decision to widen access to various anti-infectives
12 December 2017 - PHARMAC is pleased to announce our decision to widen funded access to three treatments: ...
Posted by Michael Wonder on 10 Dec 2017
Miracle drug keeping Eva McGauley's cancer at bay
10 December 2017 - Terminally ill teenager Eva McGauley is appealing for help to pay for a life-saving new cancer drug ...
Posted by Michael Wonder on 08 Dec 2017
Decision to fund methylnaltrexone in palliative care
8 December 2017 - PHARMAC is pleased to announce the approval of an agreement with Link Pharmaceuticals Limited for the ...
Posted by Michael Wonder on 07 Dec 2017
The drugs we couldn't get enough of: more than 200 cases of shortages over six years
7 December 2017 - Drugs to treat depression, Parkinson's disease, head lice, scabies and migraines ran out 11 times over ...
Posted by Michael Wonder on 07 Dec 2017
PHARMAC commits to equity target by 2025
7 December 2017 - Achieving equity in medicines access is one of the bold goals PHARMAC has set itself to ...
Posted by Michael Wonder on 04 Dec 2017
Access to new indications in New Zealand - 2017 in review
5 December 2017 - With the publication of the final issue of the New Zealand Pharmaceutical Schedule for 2017, MAESTrO ...
Posted by Michael Wonder on 03 Dec 2017
Access to new medicines in New Zealand - 2017 in review
3 December 2017 - As 2017 draws to a close and the year's last update of the New Zealand Pharmaceutical ...
Posted by Michael Wonder on 30 Nov 2017
New Zealand Pharmaceutical Schedule - 1 December 2017
1 December 2017 - The December 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Nov 2017
Multiple sclerosis sufferer Natalie Adams lives in fear
29 November 2017 - Lying in a hospital bed with her skin feeling like it had been dipped in acid, ...
Posted by Michael Wonder on 29 Nov 2017
Auckland mum is having to self-fund drugs to extend her life
28 November 2017 - All Megan Casey wants to do is see her children get married and be a grandmother. ...
Posted by Michael Wonder on 29 Nov 2017
Over-reliance in cardiovascular treatment – a supply risk that needs to change
29 November 2017 - New Zealand’s reliance on the cardiovascular medicines metoprolol succinate and cilazapril is out of step with ...